Genotypic and phenotypic profiles of escherichia coli isolates belonging to clinical sequence type 131 (ST131), clinical non-ST131, and fecal non-ST131 lineages from India

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 12, 2014, Pages 7240-7249

  Hussain, Arif ^a   Ranjan, Amit ^a   Nanwar, Nishant ^a   Babbar, Anshu ^a   Jadhav, Savita ^b   Ahmed, Niyaz ^a,c  

^a UNIVERSITY OF HYDERABAD   (India)

^b DR DY PATIL UNIVERSITY   (India)

^c UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; METALLO BETA LACTAMASE; NALIDIXIC ACID; QUINOLONE DERIVATIVE; SULFONAMIDE; TETRACYCLINE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM; ANTIINFECTIVE AGENT; BETA LACTAMASE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASSAY; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BIOFILM; BIOFILM PRODUCTION ASSAY; CLINICAL ARTICLE; CLINICAL NON SEQUENCE TYPE 131; CONJUGATION; CONTROLLED STUDY; DEMOGRAPHY; DISK DIFFUSION; ENZYME SYNTHESIS; ESCHERICHIA COLI; FECAL NON SEQUENCE TYPE 131; FECES; FEMALE; GENE IDENTIFICATION; GENETIC SIMILARITY; GENOTYPE; HORIZONTAL GENE TRANSFER; HUMAN; INDIA; INTENSIVE CARE UNIT; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PROSTATITIS; REPLICON; SEQUENCE TYPE 131; TERTIARY CARE CENTER; ZEBRA FISH; ZEBRA FISH LETHALITY ASSAY; ANIMAL; BIOASSAY; CLASSIFICATION; DNA FINGERPRINTING; DRUG EFFECTS; ESCHERICHIA COLI INFECTION; FISH DISEASE; GENE EXPRESSION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HOSPITAL; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MORTALITY; PHYLOGENY; SURVIVAL; TERTIARY HEALTH CARE; VETERINARY;

ANIMALS; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BIOFILMS; BIOLOGICAL ASSAY; DNA FINGERPRINTING; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; FISH DISEASES; GENE EXPRESSION; GENOTYPE; HOSPITALS; HUMANS; INDIA; MULTILOCUS SEQUENCE TYPING; PHENOTYPE; PHYLOGENY; SURVIVAL ANALYSIS; TERTIARY HEALTHCARE; ZEBRAFISH;

EID: 84912099582     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.03320-14     Document Type: Article

References (53)

1. Kaper JB, Nataro JP, Mobley HL. 2004. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2:123-140. http://dx.doi.org/10.1038/nrmicro818.
2. Foxman B. 2010. The epidemiology of urinary tract infection. Nat. Rev. Urol. 7:653-660. http://dx.doi.org/10.1038/nrurol.2010.190.
3. Canton R, Coque TM. 2006. The CTX-M beta-lactamase pandemic. Curr. Opin. Microbiol. 9:466-475. http://dx.doi.org/10.1016/j.mib.2006 .08.011.
4. Karim A, Poirel L, Nagarajan S, Nordmann P. 2001. Plasmid-mediated extended-spectrum beta-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1. FEMS Microbiol. Lett. 201: 237-241. http://dx.doi.org/10.1111/j.1574-6968.2001.tb10762.x.
5. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, Chaudhary U, Doumith M, Giske CG, Irfan S, Krishnan P, Kumar AV, Maharjan S, Mushtaq S, Noorie T, Paterson DL, Pearson A, Perry C, Pike R, Rao B, Ray U, Sarma JB, Sharma M, Sheridan E, Thirunarayan MA, Turton J, Upadhyay S, Warner M, Welfare W, Livermore DM, Woodford N. 2010. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect. Dis. 10:597-602. http://dx.doi.org/10.1016/S1473-3099(10)70143-2.
6. Jadhav S, Hussain A, Devi S, Kumar A, Parveen S, Gandham N, Wieler LH, Ewers C, Ahmed N. 2011. Virulence characteristics and genetic affinities of multiple drug resistant uropathogenic Escherichia coli from a semi urban locality in India. PLoS One 6:e18063. http://dx.doi.org/10 .1371/journal.pone.0018063.
7. Hussain A, Ewers C, Nandanwar N, Guenther S, Jadhav S, Wieler LH, Ahmed N. 2012. Multiresistant uropathogenic Escherichia coli from a region in India where urinary tract infections are endemic: genotypic and phenotypic characteristics of sequence type 131 isolates of the CTX-M-15 extended-spectrum-beta-lactamase-producing lineage. Antimicrob. Agents Chemother. 56:6358-6365. http://dx.doi.org/10.1128/AAC .01099-12.
8. Paterson DL, Bonomo RA. 2005. Extended-spectrum beta-lactamases: a clinical update. Clin. Microbiol. Rev. 18:657-686. http://dx.doi.org/10 .1128/CMR.18.4.657-686.2005.
9. Hawkey PM. 2008. Prevalence and clonality of extended-spectrum betalactamases in Asia. Clin. Microbiol. Infect. 14(Suppl 1):S159-S165. http: //dx.doi.org/10.1111/j.1469-0691.2007.01855.x.
10. Harish BN, Menezes GA, Shekatkar S, Parija SC. 2007. Extendedspectrum beta-lactamase-producing Klebsiella pneumoniae from blood culture. J. Med. Microbiol. 56:999-1000. http://dx.doi.org/10.1099/jmm .0.47072-0.
11. Mitka M. 2013. Indian public health leaders move to reduce antimicrobial resistance. JAMA 309:531-532. http://dx.doi.org/10.1001/jama.2013.297.
12. Vento S, Cainelli F. 2010. The need for new antibiotics. Lancet 375:637. http://dx.doi.org/10.1016/S0140-6736(10)60264-4.
13. Canton R, Coque TM, Baquero F. 2003. Multi-resistant Gram-negative bacilli: from epidemics to endemics. Curr. Opin. Infect. Dis. 16:315-325. http://dx.doi.org/10.1097/00001432-200308000-00003.
14. Rogers BA, Sidjabat HE, Paterson DL. 2011. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J. Antimicrob. Chemother. 66:1-14. http://dx.doi.org/10.1093/jac/dkq415.
15. Lavigne JP, Vergunst AC, Goret L, Sotto A, Combescure C, Blanco J, O'Callaghan D, Nicolas-Chanoine MH. 2012. Virulence potential and genomic mapping of the worldwide clone Escherichia coli ST131. PLoS One 7:e34294. http://dx.doi.org/10.1371/journal.pone.0034294.
16. Clark G, Paszkiewicz K, Hale J, Weston V, Constantinidou C, Penn C, Achtman M, McNally A. 2012. Genomic analysis uncovers a phenotypically diverse but genetically homogeneous Escherichia coli ST131 clone circulating in unrelated urinary tract infections. J. Antimicrob. Chemother. 67:868-877. http://dx.doi.org/10.1093/jac/dkr585.
17. Avasthi TS, Kumar N, Baddam R, Hussain A, Nandanwar N, Jadhav S, Ahmed N. 2011. Genome of multidrug-resistant uropathogenic Escherichia coli strain NA114 from India. J. Bacteriol. 193:4272-4273. http://dx .doi.org/10.1128/JB.05413-11.
18. Totsika M, Beatson SA, Sarkar S, Phan MD, Petty NK, Bachmann N, Szubert M, Sidjabat HE, Paterson DL, Upton M, Schembri MA. 2011. Insights into a multidrug resistant Escherichia coli pathogen of the globally disseminated ST131 lineage: genome analysis and virulence mechanisms. PLoS One 6:e26578. http://dx.doi.org/10.1371/journal.pone.0026578.
19. Coque TM, Novais A, Carattoli A, Poirel L, Pitout J, Peixe L, Baquero F, Canton R, Nordmann P. 2008. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg. Infect. Dis. 14:195-200. http://dx.doi.org/10.3201 /eid1402.070350.
20. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. 2010. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin. Infect. Dis. 51:286-294. http://dx.doi.org/10.1086/653932.
21. Bonnin RA, Poirel L, Carattoli A, Nordmann P. 2012. Characterization of an IncFII plasmid encoding NDM-1 from Escherichia coli ST131. PLoS One 7:e34752. http://dx.doi.org/10.1371/journal.pone.0034752.
22. Carattoli A. 2009. Resistance plasmid families in Enterobacteriaceae. Antimicrob. Agents Chemother. 53:2227-2238. http://dx.doi.org/10.1128 /AAC.01707-08.
23. Mazurek J, Pusz P, Bok E, Stosik M, Baldy-Chudzik K. 2013. The phenotypic and genotypic characteristics of antibiotic resistance in Escherichia coli populations isolated from farm animals with different exposure to antimicrobial agents. Pol. J. Microbiol. 62:173-179. http://dx.doi .org/10.1099/jmm.0.051243-0.
24. Verraes C, Van Boxstael S, Van Meervenne E, Van Coillie E, Butaye P, Catry B, de Schaetzen MA, Van Huffel X, Imberechts H, Dierick K, Daube G, Saegerman C, De Block J, Dewulf J, Herman L. 2013. Antimicrobial resistance in the food chain: a review. Int. J. Environ. Res. Public Health 10:2643-2669. http://dx.doi.org/10.3390/ijerph10072643.
25. Clermont O, Dhanji H, Upton M, Gibreel T, Fox A, Boyd D, Mulvey MR, Nordmann P, Ruppe E, Sarthou JL, Frank T, Vimont S, Arlet G, Branger C, Woodford N, Denamur E. 2009. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J. Antimicrob. Chemother. 64:274-277. http://dx.doi .org/10.1093/jac/dkp194.
26. Schissler JR, Hillier A, Daniels JB, Cole LK, Gebreyes WA. 2009. Evaluation of Clinical and Laboratory Standards Institute interpretive criteria for methicillin-resistant Staphylococcus pseudintermedius isolated from dogs. J. Vet. Diagn. Invest. 21:684-688. http://dx.doi.org/10.1177 /104063870902100514.
27. Anderson KF, Lonsway DR, Rasheed JK, Biddle J, Jensen B, McDougal LK, Carey RB, Thompson A, Stocker S, Limbago B, Patel JB. 2007. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J. Clin. Microbiol. 45:2723-2725. http://dx .doi.org/10.1128/JCM.00015-07.
28. Rodriguez-Siek KE, Giddings CW, Doetkott C, Johnson TJ, Nolan LK. 2005. Characterizing the APEC pathotype. Vet. Res. 36:241-256. http://dx .doi.org/10.1051/vetres:2004057.
29. Bertrand S, Weill FX, Cloeckaert A, Vrints M, Mairiaux E, Praud K, Dierick K, Wildemauve C, Godard C, Butaye P, Imberechts H, Grimont PA, Collard JM. 2006. Clonal emergence of extended-spectrum betalactamase (CTX-M-2)-producing Salmonella enterica serovar Virchow isolates with reduced susceptibilities to ciprofloxacin among poultry and humans in Belgium and France (2000 to 2003). J. Clin. Microbiol. 44: 2897-2903. http://dx.doi.org/10.1128/JCM.02549-05.
30. Bert F, Branger C, Lambert-Zechovsky N. 2002. Identification of PSE and OXA beta-lactamase genes in Pseudomonas aeruginosa using PCRrestriction fragment length polymorphism. J. Antimicrob. Chemother. 50:11-18. http://dx.doi.org/10.1093/jac/dkf069.
31. Boerlin P, Travis R, Gyles CL, Reid-Smith R, Janecko N, Lim H, Nicholson V, McEwen SA, Friendship R, Archambault M. 2005. Antimicrobial resistance and virulence genes of Escherichia coli isolates from swine in Ontario. Appl. Environ. Microbiol. 71:6753-6761. http://dx.doi .org/10.1128/AEM.71.11.6753-6761.2005.
32. Ewers C, Janssen T, Kiessling S, Philipp HC, Wieler LH. 2004. Molecular epidemiology of avian pathogenic Escherichia coli (APEC) isolated from colisepticemia in poultry. Vet. Microbiol. 104:91-101. http://dx.doi .org/10.1016/j.vetmic.2004.09.008.
33. Jouini A, Vinue L, Slama KB, Saenz Y, Klibi N, Hammami S, Boudabous A, Torres C. 2007. Characterization of CTX-M and SHV extendedspectrum beta-lactamases and associated resistance genes in Escherichia coli strains of food samples in Tunisia. J. Antimicrob. Chemother. 60: 1137-1141. http://dx.doi.org/10.1093/jac/dkm316.
34. Robicsek A, Strahilevitz J, Sahm DF, Jacoby GA, Hooper DC. 2006. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob. Agents Chemother. 50:2872-2874. http://dx .doi.org/10.1128/AAC.01647-05.
35. Pfeifer Y, Wilharm G, Zander E, Wichelhaus TA, Gottig S, Hunfeld KP, Seifert H, Witte W, Higgins PG. 2011. Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007. J. Antimicrob. Chemother. 66:1998-2001. http://dx.doi.org/10 .1093/jac/dkr256.
36. Skurnik D, Le Menac'h A, Zurakowski D, Mazel D, Courvalin P, Denamur E, Andremont A, Ruimy R. 2005. Integron-associated antibiotic resistance and phylogenetic grouping of Escherichia coli isolates from healthy subjects free of recent antibiotic exposure. Antimicrob. Agents Chemother. 49:3062-3065. http://dx.doi.org/10.1128/AAC.49.7.3062-3065.2005.
37. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. 2005. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods 63:219-228. http://dx.doi.org/10.1016/j.mimet.2005.03.018.
38. Clermont O, Bonacorsi S, Bingen E. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558. http://dx.doi.org/10.1128/AEM.66.10.4555-4558.2000.
39. Bingen E, Picard B, Brahimi N, Mathy S, Desjardins P, Elion J, Denamur E. 1998. Phylogenetic analysis of Escherichia coli strains causing neonatal meningitis suggests horizontal gene transfer from a predominant pool of highly virulent B2 group strains. J. Infect. Dis. 177:642-650. http: //dx.doi.org/10.1086/514217.
40. Chao CC, Hsu PC, Jen CF, Chen IH, Wang CH, Chan HC, Tsai PW, Tung KC, Wang CH, Lan CY, Chuang YJ. 2010. Zebrafish as a model host for Candida albicans infection. Infect. Immun. 78:2512-2521. http: //dx.doi.org/10.1128/IAI.01293-09.
41. Versalovic J, Koeuth T, Lupski JR. 1991. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res. 19:6823-6831. http://dx.doi.org/10.1093/nar /19.24.6823.
42. Novais A, Pires J, Ferreira H, Costa L, Montenegro C, Vuotto C, Donelli G, Coque TM, Peixe L. 2012. Characterization of globally spread Escherichia coli ST131 isolates (1991 to 2010). Antimicrob. Agents Chemother. 56:3973-3976. http://dx.doi.org/10.1128/AAC.00475-12.
43. Price LB, Johnson JR, Aziz M, Clabots C, Johnston B, Tchesnokova V, Nordstrom L, Billig M, Chattopadhyay S, Stegger M, Andersen PS, Pearson T, Riddell K, Rogers P, Scholes D, Kahl B, Keim P, Sokurenko EV. 2013. The epidemic of extended-spectrum-beta-lactamaseproducing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx. mBio 4(6):e00377-13. http://dx.doi.org/10.1128/mBio .00377-13.
44. Chung HC, Lai CH, Lin JN, Huang CK, Liang SH, Chen WF, Shih YC, Lin HH, Wang JL. 2012. Bacteremia caused by extended-spectrum-beta-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality. Antimicrob. Agents Chemother. 56:618-622. http://dx.doi.org /10.1128/AAC.05753-11.
45. Nicolas-Chanoine MH, Robert J, Vigan M, Laouenan C, Brisse S, Mentre F, Jarlier V. 2013. Different factors associated with CTX-Mproducing ST131 and non-ST131 Escherichia coli clinical isolates. PLoS One 8:e72191. http://dx.doi.org/10.1371/journal.pone.0072191.
46. Johnson JR, Miller S, Johnston B, Clabots C, Debroy C. 2009. Sharing of Escherichia coli sequence type ST131 and other multidrug-resistant and urovirulent E. coli strains among dogs and cats within a household. J. Clin. Microbiol. 47:3721-3725. http://dx.doi.org/10.1128/JCM.01581-09.
47. Johnson JR, Urban C, Weissman SJ, Jorgensen JH, Lewis JS, II, Hansen G, Edelstein PH, Robicsek A, Cleary T, Adachi J, Paterson D, Quinn J, Hanson ND, Johnston BD, Clabots C, Kuskowski MA, AMERECUS Investigators. 2012. Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-beta-lactamase-producing E. coli from the United States, 2000 to 2009. Antimicrob. Agents Chemother. 56:2364-2370. http://dx.doi.org /10.1128/AAC.05824-11.
48. Johnson JR, Porter SB, Zhanel G, Kuskowski MA, Denamur E. 2012. Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype. Infect. Immun. 80:1554-1562. http://dx.doi.org/10 .1128/IAI.06388-11.
49. Alqasim A, Emes R, Clark G, Newcombe J, La Ragione R, McNally A. 2014. Phenotypic microarrays suggest Escherichia coli ST131 is not a metabolically distinct lineage of extra-intestinal pathogenic E. coli. PLoS One 9:e88374. http://dx.doi.org/10.1371/journal.pone.0088374.
50. Gibreel TM, Dodgson AR, Cheesbrough J, Fox AJ, Bolton FJ, Upton M. 2012. Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from northwest England. J. Antimicrob. Chemother. 67:346-356. http://dx.doi.org/10.1093/jac/dkr451.
51. Le Bouguenec C, Schouler C. 2011. Sugar metabolism, an additional virulence factor in enterobacteria. Int. J. Med. Microbiol. 301:1-6. http: //dx.doi.org/10.1016/j.ijmm.2010.04.021.
52. Gibreel TM, Dodgson AR, Cheesbrough J, Bolton FJ, Fox AJ, Upton M. 2012. High metabolic potential may contribute to the success of ST131 uropathogenic Escherichia coli. J. Clin. Microbiol. 50:3202-3207. http: //dx.doi.org/10.1128/JCM.01423-12.
53. Wiles TJ, Bower JM, Redd MJ, Mulvey MA. 2009. Use of zebrafish to probe the divergent virulence potentials and toxin requirements of extraintestinal pathogenic Escherichia coli. PLoS Pathog. 5:e1000697. http: //dx.doi.org/10.1371/journal.ppat.1000697.